NASDAQ: CNXUConexeu Sciences Inc Stock Ownership - Who owns Conexeu Sciences?
Insider buying vs selling
Have Conexeu Sciences Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| David Robert Bogart | CCO | 2026-09-25 | 750,000 | $0.00 | $750.00Buy |
| Jeffrey Nathan Sharpe | Director | 2026-09-14 | 500,000 | $0.00 | $500.00Buy |
| Lynn Sebastian Purcell | Director | 2026-09-04 | 217,608 | $2.30 | $500.50kBuy |
| Lynn Sebastian Purcell | Director | 2026-09-04 | 217,608 | $2.30 | $500.50kBuy |
| Michael G. Wright | 10% Owner | 2026-06-18 | 250,000 | $0.00 | $250.00Buy |
| Lynn Sebastian Purcell | Director | 2026-06-18 | 202,500 | $0.80 | $162.00kBuy |
| Michael G. Wright | 10% Owner | 2026-05-26 | 400,000 | $0.00 | $400.00Buy |
| Jeffrey Nathan Sharpe | Director | 2026-05-22 | 500,000 | $0.00 | $500.00Buy |
CNXU insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CNXU insiders and whales buy or sell their stock.
CNXU Shareholders
What type of owners hold Conexeu Sciences Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Lynn Sebastian Purcell | 20.16% | 5,686,088 | $18.82M | Insider |
| Michael G. Wright | 10.27% | 2,898,048 | $9.59M | Insider |
| David Robert Bogart | 7.95% | 2,243,750 | $7.43M | Insider |
| Jeffrey Nathan Sharpe | 5.32% | 1,500,000 | $4.97M | Insider |
| Zbigniew Paul Lorenc | 1.54% | 433,323 | $1.43M | Insider |
| Ubs Group Ag | 0.00% | 12 | $39.72 | Institution |
| Ubsgro | 0.00% | 12 | $39.72 | Institution |
| Morsta | 0.00% | 6 | $19.86 | Institution |
| Citigroup Inc | 0.00% | 5 | $16.55 | Institution |
| Morgan Stanley | 0.00% | 5 | $16.55 | Institution |
CNXU vs Biotech Stocks
Conexeu Sciences Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.